Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,599.00
Bid: 1,594.50
Ask: 1,595.50
Change: -19.00 (-1.17%)
Spread: 1.00 (0.063%)
Open: 1,608.00
High: 1,615.00
Low: 1,575.00
Prev. Close: 1,618.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Footsie advances as Barclays rebounds

Mon, 02nd Jul 2012 11:41

- Better-than-expected manufacturing data from Asia- Eurozone jobless rate at all-time high- UK manufacturing PMI beats forecastsLondon's blue-chip index held on to gains on Monday morning with Barclays leading the risers as it continues to rebound after last week's sharp falls.Economic data from Asia helped to lift sentiment early on: China's purchasing managers' index (PMI) fell from 50.4 to 50.2 last month, according to the National Bureau of Statistics and China Federation of Logistics and Purchasing, beating forecasts of around 49.9; while Japan's Tankan manufacturers' sentiment survey improved from minus four to minus one in the second quarter, compared to expectations of an unchanged reading. The Eurozone's unemployment rate rose to 11.1% in May, in line with estimates and the highest since the creation of the Eurozone, according to the latest data from the region's statistics office, Eurostat. In domestic news, UK manufacturing PMI rose from 45.9 to 48.6 in June, well ahead of expectations of 46.5. However, with the sector still contracting (readings below 50 points), the pressure is mounting for the Bank of England to ramp up its asset purchase programme on Thursday when it announces its July policy decision.FTSE 100: Barclays rebounds after recent sell-offBarclays, the bank which last week was given a £290m fine for manipulating interbank lending rates, was a high riser today after revealing that its Chairman Macrus Agius has resigned. After numerous calls for CEO Bob Diamond to follow in Agius's footsteps, Investec analyst Ian Gordon said this morning that investors should "back Bob" and take advantage of the stock's recent underperformance.Royal Bank of Scotland (RBS) was flat after Oriel Securities downgraded its rating on the stock to 'hold'. It was revealed at the weekend that the bank had sacked several traders last year over the alleged manipulation of LIBOR. Insurance group Aviva advanced after announcing that Lord Colin Sharman has retired as Chairman and has been replaced by John McFarlane.Pharmaceuticals giant GlaxoSmithKline rose after revealing positive results from four pivotal phase III studies for its once-daily COPD treatment. The company said that the results of the studies support its intention to commence global regulatory submissions for the treatment from the end of 2012. Sector peer AstraZeneca was flat despite saying that Bristol-Myers Squibb's acquisition of Amylin Pharmaceuticals will strengthen the leadership position of its diabetes alliance with Bristol-Myers in a "growing area of high unmet medical need". Astra will make a payment of $3.4bn in cash to Amylin once it becomes a wholly-owned subsidiary of Bristol-Myers. Serco, the international services company, rose after it signed an agreement to dispose of most of its operations in Germany in a transaction with the local management team. FTSE 250: SOCO jumps over 8%Oil and gas group SOCO International surged after entering into a 'conditional' agreement with Lizeroux Oil & Gas to acquire the 20% minority interest in SOCO Vietnam that the group does not already own. Insurance group Catlin fell after Jefferies downgraded the stock as part of its review into the European insurance industry: "With Catlin now close to our price target, we downgrade to 'hold' also noting higher end US windstorm exposure and a broadly untouched reinsurance deductible." FTSE 100 - RisersBarclays (BARC) 168.65p +3.56%Aviva (AV.) 281.90p +3.41%Petrofac Ltd. (PFC) 1,427.00p +2.81%Weir Group (WEIR) 1,571.00p +2.68%Whitbread (WTB) 2,071.00p +2.12%BP (BP.) 430.05p +1.92%Rio Tinto (RIO) 3,077.00p +1.92%Amec (AMEC) 1,021.00p +1.90%Prudential (PRU) 751.00p +1.76%WPP (WPP) 786.50p +1.75%FTSE 100 - FallersShire Plc (SHP) 1,782.00p -2.73%British Sky Broadcasting Group (BSY) 688.00p -1.22%Smith & Nephew (SN.) 630.00p -1.18%Vodafone Group (VOD) 177.45p -1.00%Admiral Group (ADM) 1,183.00p -0.76%Morrison (Wm) Supermarkets (MRW) 264.40p -0.64%Pearson (PSON) 1,259.00p -0.55%AstraZeneca (AZN) 2,838.00p -0.53%Next (NXT) 3,184.00p -0.47%Capital Shopping Centres Group (CSCG) 320.90p -0.34%FTSE 250 - RisersSoco International (SIA) 310.90p +7.43%Imagination Technologies Group (IMG) 499.50p +7.05%Fenner (FENR) 380.80p +5.40%Aquarius Platinum Ltd. (AQP) 48.11p +5.37%Kenmare Resources (KMR) 41.50p +5.06%Travis Perkins (TPK) 1,019.00p +5.00%Ashtead Group (AHT) 271.40p +4.42%Shanks Group (SKS) 79.25p +3.80%Smith (DS) (SMDS) 152.70p +3.60%Oxford Instruments (OXIG) 1,269.00p +3.42%FTSE 250 - FallersAvocet Mining (AVM) 81.00p -10.05%Ocado Group (OCDO) 75.40p -2.96%Halfords Group (HFD) 223.60p -2.44%Euromoney Institutional Investor (ERM) 731.00p -2.08%Spirit Pub Company (SPRT) 49.75p -1.97%Debenhams (DEB) 85.25p -1.45%Catlin Group Ltd. (CGL) 419.80p -1.34%Perform Group (PER) 395.00p -1.25%Ruspetro (RPO) 133.50p -1.18%Home Retail Group (HOME) 83.65p -1.18%FTSE TechMARK - RisersAsterand (ATD) 1.05p +13.51%Phytopharm (PYM) 6.20p +5.53%Timeweave (TMW) 21.00p +5.00%Hiwave Technologies (HIW) 1.50p +3.45%Gresham Computing (GHT) 61.00p +2.95%Electronic Data Processing (EDP) 43.50p +2.35%Oxford Biomedica (OXB) 2.40p +2.13%Kofax (KFX) 256.25p +2.09%NCC Group (NCC) 815.00p +2.07%Sepura (SEPU) 68.25p +1.87%FTSE TechMARK - FallersBATM Advanced Communications Ltd. (BVC) 14.00p -4.27%Emblaze Ltd. (BLZ) 51.60p -3.55%AEA Technology Group (AAT) 0.20p -2.44%Vectura Group (VEC) 76.00p -0.98%Skyepharma (SKP) 78.25p -0.95%Phoenix IT Group (PNX) 180.00p -0.83%Microgen (MCGN) 139.00p -0.71%Ricardo (RCDO) 340.00p -0.58%Psion (PON) 87.00p -0.57%Consort Medical (CSRT) 700.00p -0.57%
More News
20 Jun 2024 16:01

Industry groups back drugmakers' appeal in Zantac cancer lawsuits

June 20 (Reuters) - A bid by GSK and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued heartburn drug Zantac has received the backing of leading U.S. industry groups, including the United States Chamber of Commerce and Pharmaceutical Research and Manufacturers of America.

Read more
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.